PIK3CA c.73_74inv ;(p.L25K)

Variant ID: 3-178916686-TT-AA

NM_006218.2(PIK3CA):c.73_74inv;(p.L25K)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.

Cell
Grebien, Florian F; Hantschel, Oliver O; Wojcik, John J; Kaupe, Ines I; Kovacic, Boris B; Wyrzucki, Arkadiusz M AM; Gish, Gerald D GD; Cerny-Reiterer, Sabine S; Koide, Akiko A; Beug, Hartmut H; Pawson, Tony T; Valent, Peter P; Koide, Shohei S; Superti-Furga, Giulio G
Publication Date: 2011-10-14

Variant appearance in text: PI3K: L25K
PubMed Link: 22000011
Variant Present in the following documents:
  • Main text
View BVdb publication page